Details of the Drug
General Information of Drug (ID: DMWJN73)
Drug Name |
4-(Hydroxymercury)Benzoic Acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
p-hydroxymercuribenzoic acid; p-hydroxymercuribenzoate; (p-carboxyphenyl)hydroxymercury; 4-(HYDROXYMERCURY)BENZOIC ACID; mercury, (p-carboxyphenyl)hydroxy-; (4-carboxyphenyl)(hydroxy)mercury; (4-carboxylatophenyl)hydroxymercurate(1-) hydrogen; 1126-48-3; Sodium p-chloromercuribenzoate; Mercury, sodium salt; Mercury, monosodium salt; Mercurate(1-), sodium; SCHEMBL678164; CHEMBL78771; Mercurate(1-), (4-carboxylatophenyl)hydroxy-, hydrogen; CHEBI:49644; NSC1048; NSC-1048
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 339.72 | |||||||||||||||||||||
Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
Rotatable Bond Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Off-Target (DOT) |
|
||||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||